07.22.25 -- STREAM Edition: Meeting Cell Therapy Market Demand

Are you facing challenges in your cell culture process, such as poor cell growth, low productivity, or inconsistent product quality? This on-demand webinar offers a comprehensive overview of analytical solutions to help you overcome these hurdles. With this webinar, you will gain an understanding of how to harness the power of analytics to optimize your bioprocessing workflows and achieve significant improvements in cell culture performance. Access now >>

Commercial success in cell therapy hinges on scalable, automated manufacturing. At Phacilitate 2020, experts discussed how to meet evolving industry demands and market needs.

Endpoints News founder Arsalan Arif shares his journey and unpacks the cell and gene therapy market, from investor sentiment to the challenges of scaling innovation.

Learn about an Innovation Hub that specializes in freezing studies to provide insight into the performance of single-use cryopreservation solutions for manufacturing and delivering advanced therapies.

Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.

During this segment, Nguyen and Wagner agree that scalability will be a top concern for most CGT companies.

In this episode of the Cell & Gene podcast, Host Erin Harris speaks with Alicia Zhou, Ph.D., CEO of the Cancer Research Institute (CRI), about CRI’s mission to advance cancer immunotherapy and the critical role of federal funding, particularly from the NIH, in supporting basic and translational cancer research.